Anebulo Pharmaceuticals, Inc.
USD0.40
+0.00 (+0.00%)
CEO
Richard Anthony Cunningham
IPO Date
2021-05-07
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Open
$0.40
Prev. Close
$0.40
Day Low
$0.40
Day High
$0.40
52W Low
$0.01
52W High
$3.42
Market Cap
$0.02B
Volume
0.00M
| -8.4 |
| 30 Jun 2023 | FY | 0.0% | 0.0% | -110.7% | -100.5% | 0.00 | 10.92 | -5.0 |
| 30 Jun 2022 | FY | 0.0% | 0.0% | -45.3% | -43.8% | 0.00 | 30.40 | -17.8 |
| 30 Jun 2021 | FY | 0.0% | 0.0% | -141.3% | -139.7% | 0.00 | 89.61 | -5.3 |
| 30 Jun 2020 | FY | 0.0% | 0.0% | -6.2% | -5.8% | 0.07 | 13.53 | -964.2 |
| -11.9 |
| 30 Jun 2025 | Q4 | 0.0% | 0.0% | -18.4% | -17.7% | 0.00 | 24.53 | -6.9 |
| 31 Mar 2025 | Q3 | 0.0% | 0.0% | -12.5% | -12.0% | 0.00 | 25.29 | -5.3 |
| 31 Dec 2024 | Q2 | 0.0% | 0.0% | -16.5% | -15.5% | 0.00 | 17.52 | -4.7 |
| 30 Sept 2024 | Q1 | 0.0% | 0.0% | -115.9% | -89.2% | 0.00 | 3.45 | -5.7 |
| 30 Jun 2024 | Q4 | 0.0% | 0.0% | -35.4% | -33.1% | 0.00 | 13.46 | -12.8 |
| 31 Mar 2024 | Q3 | 0.0% | 0.0% | -33.2% | -27.6% | 0.00 | 5.32 | -11.3 |
| 31 Dec 2023 | Q2 | 0.0% | 0.0% | -41.9% | -36.2% | 0.00 | 6.73 | -5.7 |
| 30 Sept 2023 | Q1 | 0.0% | 0.0% | -29.8% | -27.4% | 0.00 | 12.63 | -7.9 |